Entering text into the input field will update the search result below

Blueprint Medicines beats by $0.03, beats on revenue

  • Blueprint Medicines  (NASDAQ:BPMC): Q2 EPS of -$0.70 beats by $0.03.
  • Revenue of $7.07M (+162.8% Y/Y) beats by $2.66M.
  • Press Release

Recommended For You

More Trending News

About BPMC Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BPMC--
Blueprint Medicines Corporation